Rifaximin EIR

DRUG2 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

Crohn's Disease

Phase 3

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

TerminatedNCT02240108

Bausch Health Americas, Inc.Crohn's Disease

Start: 2014-10-28End: 2017-10-06Updated: 2019-09-10

One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

TerminatedNCT02240121

Bausch Health Americas, Inc.Crohn's Disease

Start: 2014-08-21End: 2017-08-16Updated: 2019-09-10